Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances

The development of nanoparticles (NPs) for use in all facets of oncological disease detection and therapy has shown great progress over the past two decades. NPs have been tailored for use as contrast enhancement agents for imaging, drug delivery vehicles, and most recently as a therapeutic component in initiating tumor cell death in magnetic and photonic ablation therapies. Of the many possible core constituents of NPs, such as gold, silver, carbon nanotubes, fullerenes, manganese oxide, lipids, micelles, etc., iron oxide (or magnetite) based NPs have been extensively investigated due to their excellent superparamagnetic, biocompatible, and biodegradable properties. This review addresses recent applications…

• AR
  Achievement Rewards for College Scientists Foundation
• FA
  Fondation ARC pour la Recherche sur le Cancer
• SU
  Sichuan University of Science and Engineering
• NI
  National Institutes of Health

  Award: R01CA161953